Barbara Ruskin - 24 Mar 2023 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Director
Signature
/s/ Anthony Mack, attorney-in-fact
Issuer symbol
VRPX
Transactions as of
24 Mar 2023
Net transactions value
$0
Form type
4
Filing time
28 Mar 2023, 20:05:09 UTC
Next filing
31 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +25,000 $0.000000 25,000 24 Mar 2023 Common Stock 25,000 $0.8364 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.